Structural and Functional NIR-II Fluorescence Bioimaging in Urinary System via Clinically Approved Dye Methylene Blue
Abstract
Accurate structural and functional imaging is vital for the diagnosis and prognosis of the urinary system diseases. Near-infrared region (NIR) II fluorescence imaging has shown advantages of high sensitivity, high safety, and fast feedback compared to the conventional imaging methods but limited to its clinical applicability. Herein, we first report that in vivo NIR-II fluorescence imaging of the urinary system enabled by clinically approved and renal-clearable NIR dye methylene blue, which can not only achieve clear invasive/non-invasive urography but also noninvasively detect renal function. These results demonstrate that MB assisted NIR-II fluorescence imaging holds great promise for invasive/noninvasive structural imaging of the urinary system clinically and investigation of renal function in animal models preclinically.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protein enhanced NIR-IIb emission of indocyanine green for functional bioimaging
- Off-the-shelf NIR-I fluorophores as ready-to-use NIR-II probes: screening and in vivo validation
Marie‐Lynn Al‐Hawat, Marc K. Saba-El-Leil, Simon Matoori·bioRxiv·Aug 12, 2026
- Ultrabright NIR-II Nanoprobes for Ex Vivo Bioimaging: Protein Nanoengineering Meets Molecular Engineering
Isabella Vasquez, Asma Harun, … Indrajit Srivastava·ACS Nanoscience AuPeer-reviewed·Oct 6, 2025
- Near Infrared-II Fluorescent protein for In-vivo Imaging
Q. Sun·bioRxiv·Mar 4, 2022
- Perfecting and extending the near-infrared biological window
- Shortwave Infrared Fluorescence Imaging with the Clinically Approved Near-Infrared Dye Indocyanine Green
J. A. Carr, D. Franke, … O. T. Bruns·bioRxiv·Apr 28, 2017